Advertisement

Schmerztherapie bei Schwangeren

  • K. Strasser

Zusammenfassung

Für den Einsatz von Analgetika in der Schwangerschaft sollten folgende Gesichtspunkte besonders berücksichtigt werden:
  • Auswirkung auf das ungeborene Leben in Abhängigkeit vom Stadium der Schwangerschaft,

  • Einfluß auf die Mutter und den Schwangerschaftsverlauf,

  • Analgesie und Gestose.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Amon I, Zschiesche A, Amon K (1983) Verteilung von Salizylsäure und Hydrolyse der Azetylsalizylsäure bei menschlichen Feten in der Frühschwangerschaft. Biomed Biochim Acta 42: 997–1004PubMedGoogle Scholar
  2. 2.
    Aterman K, Holzbecher M, Ellenberger HA (1980) Salicylate levels in a stillborn infant born to a drug-addicted mother, with comments on pathology and analytical methodology. Clin Toxicol 16: 263–268PubMedCrossRefGoogle Scholar
  3. 3.
    Beaufils M, Uzan S, Donsimoni R, Colau JC (1984) Essai controle d’un traitment preventif de la preeclampsie. Resultats preliminaires. Arch Mal Coeur 77: 1226–1228Google Scholar
  4. 4.
    Brash AR, Hickey DE, Graham TP, Stahlman MT, Oates JA, Cotton RB (1981) Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med 305: 67–72Google Scholar
  5. 5.
    Cantor B, Tyler T, Nelson RM, Stein GH (1980) Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors. J Reprod Med 24: 220–223PubMedGoogle Scholar
  6. 6.
    Chasnoff IJ, Hatcher R, Burns WJ, Schnoll SH (1983) Pentazocine and tripelennamine (’T’s and blue’s’): effects on the fetus and neonate. Dev Pharmacol Ther 6: 162–169PubMedGoogle Scholar
  7. 7.
    Collins E (1981) Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 58 (Suppl 5): 57S - 62SPubMedGoogle Scholar
  8. 8.
    Elis J, Sechserova M, Stribrny J, Drabkova J (1978) The distribution of sodium salicylate in the human fetus. Int J Clin Pharmacol Biopharm 16: 365–367PubMedGoogle Scholar
  9. 9.
    Golden NL, Kind KC, Sokol RJ (1982) Propoxyphene and acetaminophen. Possible effects on the fetus. Clin Pediatr 21: 752–754Google Scholar
  10. 10.
    Halle H, Hengst P (1978) Zusatztokolyse durch Prostaglandinsynthesehemmung mit Indometacin. Z Geburtshilfe Perinatol 182: 367–70PubMedGoogle Scholar
  11. 11.
    Harker LC, Kirkpatrick SE, Friedman WF, Bloor CM (1981) Effects of indomethacin on fetal rat lungs: a possible cause of persistant fetal circulation ( PFC ). Pediatr Res 15: 147151Google Scholar
  12. 12.
    Heinonen OP, Slone D, Shapiro S (1977) Birth Defects and Drugs in Pregnancy. Publ Sciences Group Littleton/MassGoogle Scholar
  13. 13.
    Itskovitz J, Abramovici H, Brandes JM (1980) Oligohydramnion, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy. J Reprod Med 24: 137–140PubMedGoogle Scholar
  14. 14.
    Knorr K, Knorr-Gärtner h (1981) Umwelteinflüsse auf die Kindesentwicklung. In: Käser O, Friedberg V, Ober KG, Thomsen K, Zander J (Hrsg) Gynäkologie and Geburtshilfe. 2. neubearb Auflage, Bd II/1. Thieme, Stuttgart New York, S 1.30–1. 65Google Scholar
  15. 15.
    Levin DL, Fixler DE, Morriss FC, Tyson J (1978) Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr 92: 478–483PubMedCrossRefGoogle Scholar
  16. 16.
    Lovecchio JL, Krasner J, Yaffe SJ (1981) Serum protein binding of salicylate during pregnancy and the puerperium. Dev Pharmacol Ther 2: 172–179PubMedGoogle Scholar
  17. 17.
    Niederhoff H, Zahradnik HP (1983) Analgesics during pregnancy. Am J Med 75: 117–120PubMedCrossRefGoogle Scholar
  18. 18.
    Nomura T, Isa Y, Kurokawa N, Kanzaki T, Tanaka H, Tada E, Sakamoto Y (1984) Enhancement effects of barbital on the teratogenicity of aminopyrine. Toxicology 29: 281–291PubMedCrossRefGoogle Scholar
  19. 19.
    Nunez L, Larrea JL, Gil Aguado M, Reque JA, Matorras R, Minguez JA (1983) Pregnancy in 20 patients with bioprosthetic valve replacement. Chest 84: 26–28PubMedCrossRefGoogle Scholar
  20. 20.
    Ostrea EM, Lynn SM, Wayne RN, Stryker JC (1980) Tissue distribution of morphine in the newborns of addicted monkeys and humans. Clinical implications. Dev Pharmacol Ther 1: 163–170Google Scholar
  21. 21.
    Peterson RG (1985) Consequences associated with nonnarcotic analgesics in the fetus and newborn. Fed Proc 44: 2309–2313PubMedGoogle Scholar
  22. 22.
    Rakoczi I, Tihanyi K, Demeter J, Gati I (1985) Effect of acetylsalicylic acid on prostacyclin production in throphoblast. Acta Physiol Hung 65: 379–382PubMedGoogle Scholar
  23. 23.
    Randall CL, Anton RF (1984) Aspirin reduces alcohol-induced prenatal mortality andmalformations in mice. Alcoholism (NY) 8: 513–515CrossRefGoogle Scholar
  24. 24.
    Rejent TA Baik S (1985) Fatal in utero salicylism. J Forensic Sci 30: 942–944PubMedGoogle Scholar
  25. 25.
    Rudolph AM (1981) Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med 141 (Spec No 3): 358–363PubMedCrossRefGoogle Scholar
  26. 26.
    Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR (1981) Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 58 (Suppl 5): 52S - 56SPubMedGoogle Scholar
  27. 27.
    Stuart MJ, Gross SJ, Elrad H, Graeber JE (1982) Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 307: 909–912PubMedCrossRefGoogle Scholar
  28. 28.
    Szeto HH, Zervoudakis IA, Cederqvist LL, Inturrisi CE (1978) Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy. Obstet Gynecol 52: 59–62PubMedGoogle Scholar
  29. 29.
    Valette A, Reme JM, Pontonnier G, Cros J (1980) Specific binding for opiate-like drugs in the placenta. Biochem Pharmacol 29: 2657–2661PubMedCrossRefGoogle Scholar
  30. 30.
    Valette A, Tafani M, Porthe G, Pontonnier G, Cros J (1983) Placental x binding site: interaction with dynorphin and its possible implication in hCG secretion. Life Sci 33 (Suppl1): 523–526PubMedCrossRefGoogle Scholar
  31. 31.
    Veersema D, de Jong PA, van Wijck JA (1983) Indomethacin and the fetal renal nonfunction syndrome. Eur J Obstet Gynecol Reprod Biol 16: 113–121PubMedCrossRefGoogle Scholar
  32. 32.
    Wagner G (1978) Schwere intrauterine Wachstumsretardierung bei Heroinabusus der Mutter–Ein Fallbericht. Z Geburtshilfe Perinatol 182: 462–464PubMedGoogle Scholar
  33. 33.
    Walsh SW (1985) Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152: 335–340PubMedGoogle Scholar
  34. 34.
    Zuckerman H, Shalev E, Gilad G, Katzuni E (1984) Further study of the inhibition of premature labor by indomethacin. Part I. J Perinat Med 12: 19–23Google Scholar
  35. 35.
    Zuckerman H, Shalev E, Gilad G, Katzuni E (1984) Further study of the inhibition of premature labor by indomethacin Part II: double-blind study. J Perinat Med 12: 25–29PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • K. Strasser

There are no affiliations available

Personalised recommendations